Covid-19 roundup: FDA to sign off on Merck, Pfizer pills this week — report; Broad Institute finds rise of Omicron through CRISPR diagnostics

The FDA may soon sign off on two new pills from Merck and Pfizer to help treat Covid-19 before those infected end up in the hospital, according to a Bloomberg report.

An announcement from the agency may come as early as Wednesday, according to three Bloomberg...

Click to view original post